Click for best price
Pediatric AntiFlu Drugs Market Size, Share 2024
The global Pediatric Anti-Flu Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oseltamivir Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pediatric Anti-Flu Drugs include Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec and Cipla, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Anti-Flu Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Anti-Flu Drugs. This report contains market size and forecasts of Pediatric Anti-Flu Drugs in global, including the following market information:
Global Pediatric Anti-Flu Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Pediatric Anti-Flu Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Pediatric Anti-Flu Drugs companies in 2023 (%)
We surveyed the Pediatric Anti-Flu Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Anti-Flu Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pediatric Anti-Flu Drugs Market Segment Percentages, by Type, 2023 (%)
Oseltamivir
Zanamivir
Global Pediatric Anti-Flu Drugs Market, by Sales Channel, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pediatric Anti-Flu Drugs Market Segment Percentages, by Sales Channel, 2023 (%)
Hospital
Clinic
Online Sales
Others
Global Pediatric Anti-Flu Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pediatric Anti-Flu Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Anti-Flu Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Pediatric Anti-Flu Drugs revenues share in global market, 2023 (%)
Key companies Pediatric Anti-Flu Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Pediatric Anti-Flu Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Johnson & Johnson
GlaxoSmithKline (GSK)
Rostec
Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatric Anti-Flu Drugs, market overview.
Chapter 2: Global Pediatric Anti-Flu Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pediatric Anti-Flu Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric Anti-Flu Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pediatric Anti-Flu Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pediatric Anti-Flu Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pediatric Anti-Flu Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Pediatric Anti-Flu Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Anti-Flu Drugs Overall Market Size
2.1 Global Pediatric Anti-Flu Drugs Market Size: 2023 VS 2030
2.2 Global Pediatric Anti-Flu Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Pediatric Anti-Flu Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Pediatric Anti-Flu Drugs Players in Global Market
3.2 Top Global Pediatric Anti-Flu Drugs Companies Ranked by Revenue
3.3 Global Pediatric Anti-Flu Drugs Revenue by Companies
3.4 Global Pediatric Anti-Flu Drugs Sales by Companies
3.5 Global Pediatric Anti-Flu Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Pediatric Anti-Flu Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Pediatric Anti-Flu Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pediatric Anti-Flu Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pediatric Anti-Flu Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pediatric Anti-Flu Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric Anti-Flu Drugs Market Size Markets, 2023 & 2030
4.1.2 Oseltamivir
4.1.3 Zanamivir
4.2 By Type - Global Pediatric Anti-Flu Drugs Revenue & Forecasts
4.2.1 By Type - Global Pediatric Anti-Flu Drugs Revenue, 2019-2024
4.2.2 By Type - Global Pediatric Anti-Flu Drugs Revenue, 2025-2030
4.2.3 By Type - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Pediatric Anti-Flu Drugs Sales & Forecasts
4.3.1 By Type - Global Pediatric Anti-Flu Drugs Sales, 2019-2024
4.3.2 By Type - Global Pediatric Anti-Flu Drugs Sales, 2025-2030
4.3.3 By Type - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Pediatric Anti-Flu Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Sales Channel
5.1 Overview
5.1.1 By Sales Channel - Global Pediatric Anti-Flu Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Online Sales
5.1.5 Others
5.2 By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue & Forecasts
5.2.1 By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue, 2019-2024
5.2.2 By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue, 2025-2030
5.2.3 By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
5.3 By Sales Channel - Global Pediatric Anti-Flu Drugs Sales & Forecasts
5.3.1 By Sales Channel - Global Pediatric Anti-Flu Drugs Sales, 2019-2024
5.3.2 By Sales Channel - Global Pediatric Anti-Flu Drugs Sales, 2025-2030
5.3.3 By Sales Channel - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
5.4 By Sales Channel - Global Pediatric Anti-Flu Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Pediatric Anti-Flu Drugs Market Size, 2023 & 2030
6.2 By Region - Global Pediatric Anti-Flu Drugs Revenue & Forecasts
6.2.1 By Region - Global Pediatric Anti-Flu Drugs Revenue, 2019-2024
6.2.2 By Region - Global Pediatric Anti-Flu Drugs Revenue, 2025-2030
6.2.3 By Region - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Pediatric Anti-Flu Drugs Sales & Forecasts
6.3.1 By Region - Global Pediatric Anti-Flu Drugs Sales, 2019-2024
6.3.2 By Region - Global Pediatric Anti-Flu Drugs Sales, 2025-2030
6.3.3 By Region - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Pediatric Anti-Flu Drugs Revenue, 2019-2030
6.4.2 By Country - North America Pediatric Anti-Flu Drugs Sales, 2019-2030
6.4.3 US Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.4.4 Canada Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.4.5 Mexico Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Pediatric Anti-Flu Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Pediatric Anti-Flu Drugs Sales, 2019-2030
6.5.3 Germany Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.4 France Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.5 U.K. Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.6 Italy Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.7 Russia Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.5.9 Benelux Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Pediatric Anti-Flu Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Pediatric Anti-Flu Drugs Sales, 2019-2030
6.6.3 China Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.6.4 Japan Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.6.5 South Korea Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.6.7 India Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Pediatric Anti-Flu Drugs Revenue, 2019-2030
6.7.2 By Country - South America Pediatric Anti-Flu Drugs Sales, 2019-2030
6.7.3 Brazil Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.7.4 Argentina Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pediatric Anti-Flu Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Pediatric Anti-Flu Drugs Sales, 2019-2030
6.8.3 Turkey Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.8.4 Israel Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Pediatric Anti-Flu Drugs Market Size, 2019-2030
6.8.6 UAE Pediatric Anti-Flu Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Pediatric Anti-Flu Drugs Major Product Offerings
7.1.4 Roche Pediatric Anti-Flu Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Pediatric Anti-Flu Drugs Major Product Offerings
7.2.4 Johnson & Johnson Pediatric Anti-Flu Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 GlaxoSmithKline (GSK)
7.3.1 GlaxoSmithKline (GSK) Company Summary
7.3.2 GlaxoSmithKline (GSK) Business Overview
7.3.3 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Major Product Offerings
7.3.4 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales and Revenue in Global (2019-2024)
7.3.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.4 Rostec
7.4.1 Rostec Company Summary
7.4.2 Rostec Business Overview
7.4.3 Rostec Pediatric Anti-Flu Drugs Major Product Offerings
7.4.4 Rostec Pediatric Anti-Flu Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Rostec Key News & Latest Developments
7.5 Cipla
7.5.1 Cipla Company Summary
7.5.2 Cipla Business Overview
7.5.3 Cipla Pediatric Anti-Flu Drugs Major Product Offerings
7.5.4 Cipla Pediatric Anti-Flu Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Cipla Key News & Latest Developments
8 Global Pediatric Anti-Flu Drugs Production Capacity, Analysis
8.1 Global Pediatric Anti-Flu Drugs Production Capacity, 2019-2030
8.2 Pediatric Anti-Flu Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pediatric Anti-Flu Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pediatric Anti-Flu Drugs Supply Chain Analysis
10.1 Pediatric Anti-Flu Drugs Industry Value Chain
10.2 Pediatric Anti-Flu Drugs Upstream Market
10.3 Pediatric Anti-Flu Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pediatric Anti-Flu Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pediatric Anti-Flu Drugs in Global Market
Table 2. Top Pediatric Anti-Flu Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Pediatric Anti-Flu Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Pediatric Anti-Flu Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Pediatric Anti-Flu Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Pediatric Anti-Flu Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Pediatric Anti-Flu Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Pediatric Anti-Flu Drugs Product Type
Table 9. List of Global Tier 1 Pediatric Anti-Flu Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Anti-Flu Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Pediatric Anti-Flu Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Pediatric Anti-Flu Drugs Sales (K Units), 2025-2030
Table 16. By Sales Channel ? Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Sales Channel - Global Pediatric Anti-Flu Drugs Sales (K Units), 2019-2024
Table 20. By Sales Channel - Global Pediatric Anti-Flu Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Pediatric Anti-Flu Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Pediatric Anti-Flu Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Pediatric Anti-Flu Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Pediatric Anti-Flu Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Pediatric Anti-Flu Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Pediatric Anti-Flu Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Pediatric Anti-Flu Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Pediatric Anti-Flu Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Pediatric Anti-Flu Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Pediatric Anti-Flu Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Pediatric Anti-Flu Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Sales, (K Units), 2025-2030
Table 46. Roche Company Summary
Table 47. Roche Pediatric Anti-Flu Drugs Product Offerings
Table 48. Roche Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Roche Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Pediatric Anti-Flu Drugs Product Offerings
Table 52. Johnson & Johnson Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. GlaxoSmithKline (GSK) Company Summary
Table 55. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Offerings
Table 56. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 58. Rostec Company Summary
Table 59. Rostec Pediatric Anti-Flu Drugs Product Offerings
Table 60. Rostec Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Rostec Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Pediatric Anti-Flu Drugs Product Offerings
Table 64. Cipla Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Cipla Key News & Latest Developments
Table 66. Pediatric Anti-Flu Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 67. Global Pediatric Anti-Flu Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 68. Global Pediatric Anti-Flu Drugs Production by Region, 2019-2024 (K Units)
Table 69. Global Pediatric Anti-Flu Drugs Production by Region, 2025-2030 (K Units)
Table 70. Pediatric Anti-Flu Drugs Market Opportunities & Trends in Global Market
Table 71. Pediatric Anti-Flu Drugs Market Drivers in Global Market
Table 72. Pediatric Anti-Flu Drugs Market Restraints in Global Market
Table 73. Pediatric Anti-Flu Drugs Raw Materials
Table 74. Pediatric Anti-Flu Drugs Raw Materials Suppliers in Global Market
Table 75. Typical Pediatric Anti-Flu Drugs Downstream
Table 76. Pediatric Anti-Flu Drugs Downstream Clients in Global Market
Table 77. Pediatric Anti-Flu Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pediatric Anti-Flu Drugs Segment by Type in 2023
Figure 2. Pediatric Anti-Flu Drugs Segment by Sales Channel in 2023
Figure 3. Global Pediatric Anti-Flu Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pediatric Anti-Flu Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pediatric Anti-Flu Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Pediatric Anti-Flu Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pediatric Anti-Flu Drugs Revenue in 2023
Figure 9. By Type - Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Pediatric Anti-Flu Drugs Price (US$/Unit), 2019-2030
Figure 13. By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Sales Channel - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 15. By Sales Channel - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 16. By Sales Channel - Global Pediatric Anti-Flu Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 23. US Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 28. Germany Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 37. China Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Pediatric Anti-Flu Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Pediatric Anti-Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Pediatric Anti-Flu Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Pediatric Anti-Flu Drugs by Region, 2023 VS 2030
Figure 54. Pediatric Anti-Flu Drugs Industry Value Chain
Figure 55. Marketing Channels
